Extraocular Procedures Except Orbit DRG Reimbursement Guide

DRG 115 encompasses inpatient extraocular procedures except those involving the orbit, including eyelid, lacrimal, and extraocular muscle operations; it defines the clinical scope for payment grouping. This grouping matters for inpatient reimbursement because it determines the bundled payment for expected resources and affects coding specificity and case mix classification under Medicare.

DRG 115 Overview

DRG 115 covers inpatient cases involving extraocular procedures that do not involve the orbital contents, including surgical interventions on the eyelids, lacrimal apparatus, and extraocular muscles. This Diagnosis-Related Group captures procedures that are often performed for functional or corrective reasons rather than for treatment of orbital disease. It matters for Medicare payment because the grouped payment reflects expected resource use for these procedure-focused admissions and influences hospital coding and billing for inpatient ophthalmic surgical care.

Acute perioperative pain management trials testing non-opioid analgesic protocols or regional anesthesia techniques for patients undergoing extraocular procedures (eg, strabismus surgery, eyelid repair excluding orbital surgery). These studies enroll pediatric and adult patients scheduled for short-duration ocular surgeries to evaluate immediate postoperative pain scores, opioid consumption, nausea/vomiting, and time to discharge. Results inform clinicians and payers about pathways that reduce inpatient analgesic use, shorten recovery room stays, and lower complication-related costs in this DRG.
Comparative effectiveness studies evaluating different surgical techniques or adjunctive perioperative approaches (for example, minimally invasive eyelid or lacrimal procedures versus traditional open techniques, or use of antifibrotic agents during corrective extraocular muscle surgery). These trials focus on functional outcomes (ocular motility, eyelid position), reoperation rates, and complication profiles in both pediatric and adult cohorts over weeks to months. Evidence from these studies helps providers choose procedures with better long-term outcomes and helps payers assess value and long-term resource utilization associated with initial procedure selection.
Post-discharge outcomes and health services research assessing readmission rates, wound-related complications, visual function recovery, and patient-reported outcomes after extraocular procedures, including surveillance of infection, diplopia persistence, or eyelid malposition. These observational cohort studies and quality-improvement trials often involve risk stratification of medically complex patients (eg, diabetics, immunosuppressed) to identify predictors of complications and to test care pathways (eg, follow-up timing, outpatient support). Findings are relevant to hospital administrators and payers for designing discharge planning, reducing preventable readmissions, and aligning post-acute care resources with patient risk.

Acute perioperative pain management trials testing non-opioid analgesic protocols or regional anesthesia techniques for patients undergoing extraocular procedures (eg, strabismus surgery, eyelid repair excluding orbital surgery). These studies enroll pediatric and adult patients scheduled for short-duration ocular surgeries to evaluate immediate postoperative pain scores, opioid consumption, nausea/vomiting, and time to discharge. Results inform clinicians and payers about pathways that reduce inpatient analgesic use, shorten recovery room stays, and lower complication-related costs in this DRG.
Comparative effectiveness studies evaluating different surgical techniques or adjunctive perioperative approaches (for example, minimally invasive eyelid or lacrimal procedures versus traditional open techniques, or use of antifibrotic agents during corrective extraocular muscle surgery). These trials focus on functional outcomes (ocular motility, eyelid position), reoperation rates, and complication profiles in both pediatric and adult cohorts over weeks to months. Evidence from these studies helps providers choose procedures with better long-term outcomes and helps payers assess value and long-term resource utilization associated with initial procedure selection.
Post-discharge outcomes and health services research assessing readmission rates, wound-related complications, visual function recovery, and patient-reported outcomes after extraocular procedures, including surveillance of infection, diplopia persistence, or eyelid malposition. These observational cohort studies and quality-improvement trials often involve risk stratification of medically complex patients (eg, diabetics, immunosuppressed) to identify predictors of complications and to test care pathways (eg, follow-up timing, outpatient support). Findings are relevant to hospital administrators and payers for designing discharge planning, reducing preventable readmissions, and aligning post-acute care resources with patient risk.

OpenPayer

Summary & Overview

Extraocular Procedures Except Orbit: Inpatient Reimbursement Overview

DRG 115 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes